Hepatitis B edible vaccine - ProdiGene
Latest Information Update: 22 Apr 2003
At a glance
- Originator ProdiGene
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 03 Apr 2000 Preclinical development for Hepatitis B in USA (PO)
- 03 Apr 2000 New profile